Literature DB >> 29437005

S-Nitrosylation in Regulation of Inflammation and Cell Damage.

Subhajit Dasgupta1,2, Jenny-Jaramillo Gomez1, Inderjit Singh1, Mushfiquddin Khan1.   

Abstract

BACKGROUND: Cell signaling through nitric oxide (NO) is a multifaceted mechanism, which regulates metabolic activities and fate in different tissues. The peroxynitrite (ONOO-) formed as reaction product of nitric oxide radical and superoxide interacts with cell membrane phospholipids and proteins causing damage.
OBJECTIVE: The reaction kinetics to form nitrotyrosine (ONOO-tyrosine) and/or nitrosylated cysteine (ONOO-cysteine) in protein molecules during posttranslational modification and nitration of lipids are therefore critical in determining cells' signaling mechanism for survival or apoptosis.
RESULTS: The nitrosylation was found to modulate GPCRs and activation of guanylate cyclase as well as regulate NF-κB activation. The recent findings have shown the neuroprotective effects of S- nitrosylation, though mechanism is unclear.
CONCLUSION: While keeping the background in mind, we address here the biological function of NO derivatives in medicine. We target four known compounds: SNAP, SIN- 1 chloride, SNP and GSNO to understand the effect of NO in different tissues. Here we analyze the existing findings to assess therapeutic relevance of NO-signaling during inflammation, vasodilation and tolerance. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  G- protein coupled receptor; Nitric oxide; inflammation; neurodegeneration; nitrosylation.

Mesh:

Substances:

Year:  2018        PMID: 29437005     DOI: 10.2174/1389450119666180213094747

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  1 in total

1.  Nitrodi thermal water downregulates protein S‑nitrosylation in RKO cells.

Authors:  Antonietta Aversano; Francesca Wanda Rossi; Francesca Cammarota; Amato De Paulis; Paola Izzo; Marina De Rosa
Journal:  Int J Mol Med       Date:  2020-07-16       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.